Arpin蛋白在前列腺癌中的表达及临床意义(4)
[12]Zhang C，Hai L，Zhu M，et al.Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells[J].Oncotarget，2017，8(20)：33 353-33 364.
[13]Buck KB，Schaefer AW，Schoonderwoert VT，et al.Local ARP2/3-dependent actin assembly modulates applied traction force during apcam adhesion site maturation[J].Mol Biol Cell，2017，28(1)：98-110.
[14]Bendell AC，Williamson EK，Chen CS，et al.The Arp2/3 complex binding protein HS1 is required for efficient dendritic cell random migration and force generation[J].Integr Biol (Camb)，2017，9(8)：695-708.
[15]Krause M，Gautreau A.Steering cell migration：lamellipodium dynamics and the regulation of directional persistence[J].Nat Rev Mol Cell Biol，2014，15(9)：577-590.
[16]Prass M，Jacobson K，Mogilner A，et al.Direct measurement of the lamellipodial protrusive force in a migrating cell[J].J Cell Biol，2006，174(6)：767-772.
[17]Fizazi K，Bosserman L，Gao G，et al.Denosumab treatment of prostate cancer with bone metastases and increased urine n-telopeptide levels after therapy with intravenous bisphosphonates：results of a randomized phase ii trial[J].J Urol，2013，189(1 Suppl)：S51- S57； discussion S57- S58.
[18]Smith AD，Roda D，Yap TA.Strategies for modern biomarker and drug development in oncology[J].J Hematol Oncol，2014，7(7)：70-71.
(收稿日期：2018-11-12 本文編辑：许俊琴), http://www.100md.com(韩东岳 赵海军 綦海燕)
[13]Buck KB，Schaefer AW，Schoonderwoert VT，et al.Local ARP2/3-dependent actin assembly modulates applied traction force during apcam adhesion site maturation[J].Mol Biol Cell，2017，28(1)：98-110.
[14]Bendell AC，Williamson EK，Chen CS，et al.The Arp2/3 complex binding protein HS1 is required for efficient dendritic cell random migration and force generation[J].Integr Biol (Camb)，2017，9(8)：695-708.
[15]Krause M，Gautreau A.Steering cell migration：lamellipodium dynamics and the regulation of directional persistence[J].Nat Rev Mol Cell Biol，2014，15(9)：577-590.
[16]Prass M，Jacobson K，Mogilner A，et al.Direct measurement of the lamellipodial protrusive force in a migrating cell[J].J Cell Biol，2006，174(6)：767-772.
[17]Fizazi K，Bosserman L，Gao G，et al.Denosumab treatment of prostate cancer with bone metastases and increased urine n-telopeptide levels after therapy with intravenous bisphosphonates：results of a randomized phase ii trial[J].J Urol，2013，189(1 Suppl)：S51- S57； discussion S57- S58.
[18]Smith AD，Roda D，Yap TA.Strategies for modern biomarker and drug development in oncology[J].J Hematol Oncol，2014，7(7)：70-71.
(收稿日期：2018-11-12 本文編辑：许俊琴), http://www.100md.com(韩东岳 赵海军 綦海燕)